HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Probiotic Beer Headed For Increasingly Specialized 'Good Bacteria' Market

This article was originally published in The Rose Sheet

Executive Summary

National University of Singapore researchers are looking for an industry partner to market their "gut-friendly" probiotic sour beer, signaling rising awareness in the research community regarding the opportunity for probiotics. Consultant Laura Mahecha discussed the growing probiotics market in a June 28 webinar hosted by Kline & Company.

You may also be interested in...



DuPont Venture With Microbiome Startup Analyzing Probiotic Impact On Gut Health

DuPont Microbiome Venture signs agreement with BioMe Oxford to develop BioCapture ingestible capsule that samples gut health to assess the impact of probiotics and other nutrients on microbiome. Product should help shape future of precision medicine, firms say.

Church & Dwight's Gummy Plan: Health & Wellness Industry Roundup

Church & Dwight wants its Vitafusion adult line to rival its L’il Critters children's line growth; Omega Protein slumps while adjusting; Dupont boosts probiotic production; and more news in brief.

Turn Back The Clock While Getting Crocked? NAD's Sober Take On Anti-Aging Gin

Anti-aGin, a collagen-infused gin created for Warner Leisure Hotels, no longer is a competitive threat to skin care marketers, as it has been permanently discontinued, according to the National Advertising Division. Despite the playful spirit of the product's launch, its claims require substantiation like any other, NAD notes.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109346

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel